Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Détails

Ressource 1Télécharger: IPA_21555851.pdf (1827.59 [Ko])
Etat: Public
Version: Final published version
ID Serval
serval:BIB_9E5EBEDCC14D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.
Périodique
Journal of Clinical Investigation
Auteur⸱e⸱s
Baitsch L., Baumgaertner P., Devêvre E., Raghav S.K., Legat A., Barba L., Wieckowski S., Bouzourene H., Deplancke B., Romero P., Rufer N., Speiser D.E.
ISSN
1558-8238 (Electronic)
ISSN-L
0021-9738
Statut éditorial
Publié
Date de publication
2011
Volume
121
Numéro
6
Pages
2350-2360
Langue
anglais
Résumé
In chronic viral infections, CD8⁺ T cells become functionally deficient and display multiple molecular alterations. In contrast, only little is known of self- and tumor-specific CD8⁺ T cells from mice and humans. Here we determined molecular profiles of tumor-specific CD8⁺ T cells from melanoma patients. In peripheral blood from patients vaccinated with CpG and the melanoma antigen Melan-A/MART-1 peptide, we found functional effector T cell populations, with only small but nevertheless significant differences in T cells specific for persistent herpesviruses (EBV and CMV). In contrast, Melan-A/MART-1-specific T cells isolated from metastases from patients with melanoma expressed a large variety of genes associated with T cell exhaustion. The identified exhaustion profile revealed extended molecular alterations. Our data demonstrate a remarkable coexistence of effector cells in circulation and exhausted cells in the tumor environment. Functional T cell impairment is mediated by inhibitory receptors and further molecular pathways, which represent potential targets for cancer therapy.
Mots-clé
CD8-Positive T-Lymphocytes/immunology, CD8-Positive T-Lymphocytes/metabolism, Cancer Vaccines/immunology, Cancer Vaccines/therapeutic use, CpG Islands/immunology, Cytomegalovirus/immunology, Cytomegalovirus Infections/immunology, Epstein-Barr Virus Infections/immunology, Gene Expression Profiling, Herpesvirus 4, Human/immunology, Humans, Lymphocytes, Tumor-Infiltrating/immunology, MART-1 Antigen/immunology, Melanoma/immunology, Melanoma/secondary, Molecular Sequence Data, Receptors, Immunologic/biosynthesis, Receptors, Immunologic/genetics, T-Cell Antigen Receptor Specificity, T-Lymphocyte Subsets/immunology, T-Lymphocyte Subsets/metabolism, Vaccination, Virus Latency/immunology
Pubmed
Web of science
Open Access
Oui
Création de la notice
13/01/2012 16:45
Dernière modification de la notice
20/08/2019 16:04
Données d'usage